Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
SuperTrans Medical
SuperTrans Medical Overview
SuperTrans Medical is a biopharmaceutical company developing novel antibiotics that target difficult-to-treat, multidrug-resistant bacteria often known as superbugs.
The companys guanidinium-rich molecular transporter (GR-MoTr) technology used in conjunction with existing FDA-approved antibiotics results in superior antimicrobial properties.
SuperTrans Medical is committed to an expedited development program and a shorter path to the clinic.
SuperTrans Medical supported by U.S. National Institutes of Health (NIH) in developing its lead antibiotic against urgent threat drug resistant bacteria
#Investment
Mar 15, 2021
www.prnewswire.com
SuperTrans Medical appoints Australian partners to provide crucial clinical research in the battle against drug-resistant bacteria
SuperTrans Medical supported by U.S. National Institutes of Health (NIH) in developing its lead antibiotic against urgent threat drug resistant bacteria
#Investment
Mar 15, 2021
www.prnewswire.com
SuperTrans Medical appoints Australian partners to provide crucial clinical research in the battle against drug-resistant bacteria
#Partners
View other companies you might be interested in
SuperTrans Medical Team
No Data, yet.
Sorry, no content found under this section.
View other companies you might be interested in
Connect with
What is the reason for connecting? *
Your company *
Company website (recommended)
Please enter a valid website
Your organization type *
Please enter a valid organization type
Your position *
Add invitation message
0/300
Sending invitation...
Invitation sent
You will be able to start a conversation once [Name] accepts it.